ConductScience.org, home

Comparison · NCT04789330-66f1102e

Norepinephrine vs Phenylephrine: Number of Participants With Severe Acute Kidney Injury

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Norepinephrine vs Phenylephrine: Number of Participants With Severe Acute Kidney Injury. Trial comparisons, record NCT04789330-66f1102e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04789330-66f1102e

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01550.01070.0223wilson
Risk in group 20.01710.0120.0241wilson
Risk difference, group 1 minus group 2-0.00158-0.01010.00687newcombe hybrid score
Risk ratio, group 1 over group 20.9070.5471.51log
Odds ratio, group 1 over group 20.9060.5411.52log
Number needed to treat, for one fewer participant with the outcome on Norepinephrine than on Phenylephrine632from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1NorepinephrineNorepinephrine continuous infusion as the first line vasopressor~Norepinephrine: Norepinephrine administered during anesthesia281,809OG000
Group 2PhenylephrinePhenylephrine continuous infusion as the first line vasopressor~Phenylephrine: Phenylephrine administered during anesthesia311,817OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Severe Acute Kidney Injury
Description
Severe acute kidney injury is assessed using the KDIGO definition based on serum creatinine or need for Renal Replacement Therapy (RRT). Severe Acute Kidney Injury is defined as an increase in serum creatinine ≥ 2-fold from baseline within 7 days, or initiation of renal replacement therapy within 7 days.
Time frame
7 days
Population

Source ClinicalTrials.gov

Trial

Title
Norepinephrine vs Phenylephrine During General Anesthesia
NCT number
NCT04789330
Phases
PHASE4
Conditions
Anesthesia, Surgery, Hypotension
Interventions
Norepinephrine, Phenylephrine
Lead sponsor
University of California, San Francisco
Results first posted
2025-12-18

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04789330-66f1102e